BMRN
Price
$56.65
Change
+$1.38 (+2.50%)
Updated
Jun 6 closing price
Capitalization
10.6B
58 days until earnings call
FULC
Price
$7.25
Change
+$0.14 (+1.97%)
Updated
Jun 6 closing price
Capitalization
383.52M
59 days until earnings call
Interact to see
Advertisement

BMRN vs FULC

Header iconBMRN vs FULC Comparison
Open Charts BMRN vs FULCBanner chart's image
BioMarin Pharmaceutical
Price$56.65
Change+$1.38 (+2.50%)
Volume$2.13M
Capitalization10.6B
Fulcrum Therapeutics
Price$7.25
Change+$0.14 (+1.97%)
Volume$388.35K
Capitalization383.52M
BMRN vs FULC Comparison Chart
Loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMRN vs. FULC commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Buy and FULC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (BMRN: $58.09 vs. FULC: $6.90)
Brand notoriety: BMRN and FULC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 109% vs. FULC: 178%
Market capitalization -- BMRN: $10.6B vs. FULC: $383.52M
BMRN [@Biotechnology] is valued at $10.6B. FULC’s [@Biotechnology] market capitalization is $383.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileFULC’s FA Score has 1 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • FULC’s FA Score: 1 green, 4 red.
According to our system of comparison, FULC is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 2 TA indicator(s) are bullish while FULC’s TA Score has 3 bullish TA indicator(s).

  • BMRN’s TA Score: 2 bullish, 3 bearish.
  • FULC’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BMRN is a better buy in the short-term than FULC.

Price Growth

BMRN (@Biotechnology) experienced а -0.67% price change this week, while FULC (@Biotechnology) price change was +10.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

BMRN is expected to report earnings on Aug 05, 2025.

FULC is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($10.6B) has a higher market cap than FULC($384M). FULC YTD gains are higher at: 46.809 vs. BMRN (-11.623). BMRN has higher annual earnings (EBITDA): 651M vs. FULC (-18.24M). BMRN has more cash in the bank: 1.14B vs. FULC (241M). FULC has less debt than BMRN: FULC (8.63M) vs BMRN (603M). BMRN has higher revenues than FULC: BMRN (2.85B) vs FULC (80M).
BMRNFULCBMRN / FULC
Capitalization10.6B384M2,760%
EBITDA651M-18.24M-3,569%
Gain YTD-11.62346.809-25%
P/E Ratio20.47N/A-
Revenue2.85B80M3,568%
Total Cash1.14B241M472%
Total Debt603M8.63M6,988%
FUNDAMENTALS RATINGS
BMRN vs FULC: Fundamental Ratings
BMRN
FULC
OUTLOOK RATING
1..100
625
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
27
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7792
PRICE GROWTH RATING
1..100
8035
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FULC's Valuation (27) in the null industry is somewhat better than the same rating for BMRN (64) in the Biotechnology industry. This means that FULC’s stock grew somewhat faster than BMRN’s over the last 12 months.

FULC's Profit vs Risk Rating (100) in the null industry is in the same range as BMRN (100) in the Biotechnology industry. This means that FULC’s stock grew similarly to BMRN’s over the last 12 months.

BMRN's SMR Rating (77) in the Biotechnology industry is in the same range as FULC (92) in the null industry. This means that BMRN’s stock grew similarly to FULC’s over the last 12 months.

FULC's Price Growth Rating (35) in the null industry is somewhat better than the same rating for BMRN (80) in the Biotechnology industry. This means that FULC’s stock grew somewhat faster than BMRN’s over the last 12 months.

BMRN's P/E Growth Rating (98) in the Biotechnology industry is in the same range as FULC (100) in the null industry. This means that BMRN’s stock grew similarly to FULC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRNFULC
RSI
ODDS (%)
N/A
Bearish Trend 12 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
64%
Bearish Trend 12 days ago
85%
Momentum
ODDS (%)
Bearish Trend 12 days ago
79%
N/A
MACD
ODDS (%)
Bearish Trend 12 days ago
68%
Bearish Trend 12 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
64%
Bullish Trend 12 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
62%
Bullish Trend 12 days ago
87%
Advances
ODDS (%)
Bullish Trend 20 days ago
60%
Bullish Trend 21 days ago
86%
Declines
ODDS (%)
Bearish Trend 18 days ago
62%
Bearish Trend 18 days ago
86%
BollingerBands
ODDS (%)
N/A
Bearish Trend 12 days ago
87%
Aroon
ODDS (%)
N/A
Bullish Trend 12 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with ITOS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then ITOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
-0.03%
ITOS - BMRN
50%
Loosely correlated
+17.94%
IBO - BMRN
46%
Loosely correlated
-6.44%
IONS - BMRN
43%
Loosely correlated
-2.67%
TECH - BMRN
40%
Loosely correlated
-1.56%
KRYS - BMRN
40%
Loosely correlated
-2.44%
More

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with ANNX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then ANNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
+8.66%
ANNX - FULC
40%
Loosely correlated
+3.05%
VRDN - FULC
40%
Loosely correlated
-3.09%
RARE - FULC
39%
Loosely correlated
-2.08%
BMRN - FULC
38%
Loosely correlated
-0.03%
PTGX - FULC
37%
Loosely correlated
-1.46%
More